367 related articles for article (PubMed ID: 18684282)
41. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator.
Pedersen SS; Hoogwegt MT; Jordaens L; Theuns DA
Am J Cardiol; 2011 Jul; 108(1):69-74. PubMed ID: 21529736
[TBL] [Abstract][Full Text] [Related]
42. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
[TBL] [Abstract][Full Text] [Related]
43. Physical function of patients with implantable cardioverter-defibrillators.
Kim JS; Pressler SJ; Welch JL; Damush T; Sloan RS; Wu J; Groh WJ
J Cardiovasc Nurs; 2009; 24(5):398-409. PubMed ID: 19707100
[TBL] [Abstract][Full Text] [Related]
44. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator.
Luyster FS; Hughes JW; Gunstad J
J Cardiovasc Nurs; 2009; 24(1):10-7. PubMed ID: 19114795
[TBL] [Abstract][Full Text] [Related]
45. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.
Giedrimas A; Giedrimiene D; Guertin D; White CM; Clyne CA; Kluger J
Conn Med; 2008; 72(6):329-33. PubMed ID: 18610705
[TBL] [Abstract][Full Text] [Related]
46. Psychological effects of implantable cardioverter-defibrillator leads under advisory.
Heatherly SJ; Simmons T; Fitzgerald DM; Mitchell M
Pacing Clin Electrophysiol; 2011 Jun; 34(6):694-9. PubMed ID: 21410721
[TBL] [Abstract][Full Text] [Related]
47. Psychopathology in patients with ICDs over time: results of a prospective study.
Kapa S; Rotondi-Trevisan D; Mariano Z; Aves T; Irvine J; Dorian P; Hayes DL
Pacing Clin Electrophysiol; 2010 Feb; 33(2):198-208. PubMed ID: 19930108
[TBL] [Abstract][Full Text] [Related]
48. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
[TBL] [Abstract][Full Text] [Related]
49. Anxiety and risk of ventricular arrhythmias or mortality in patients with an implantable cardioverter defibrillator.
Habibović M; Pedersen SS; van den Broek KC; Theuns DA; Jordaens L; van der Voort PH; Alings M; Denollet J
Psychosom Med; 2013 Jan; 75(1):36-41. PubMed ID: 23197843
[TBL] [Abstract][Full Text] [Related]
50. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life.
Bostwick JM; Sola CL
Psychiatr Clin North Am; 2007 Dec; 30(4):677-88. PubMed ID: 17938040
[TBL] [Abstract][Full Text] [Related]
51. Noncardiac chest pain in the emergency department: the role of cardiac history, anxiety or depression and Type D personality.
Kuijpers PM; Denollet J; Wellens HJ; Crijns HM; Honig A
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):273-9. PubMed ID: 17446807
[TBL] [Abstract][Full Text] [Related]
52. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias.
Burg MM; Lampert R; Joska T; Batsford W; Jain D
Psychosom Med; 2004; 66(6):898-902. PubMed ID: 15564355
[TBL] [Abstract][Full Text] [Related]
53. Type-D personality and depressive symptoms predict anxiety 12 months post-percutaneous coronary intervention.
van Gestel YR; Pedersen SS; van de Sande M; de Jaegere PP; Serruys PW; Erdman RA; van Domburg RT
J Affect Disord; 2007 Nov; 103(1-3):197-203. PubMed ID: 17346801
[TBL] [Abstract][Full Text] [Related]
54. Shock anxiety among implantable cardioverter defibrillator recipients with recent tachyarrhythmia.
Morken IM; Isaksen K; Karlsen B; Norekvål TM; Bru E; Larsen AI
Pacing Clin Electrophysiol; 2012 Nov; 35(11):1369-76. PubMed ID: 22946670
[TBL] [Abstract][Full Text] [Related]
55. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety.
Schulz SM; Massa C; Grzbiela A; Dengler W; Wiedemann G; Pauli P
Heart Lung; 2013; 42(2):105-11. PubMed ID: 23110854
[TBL] [Abstract][Full Text] [Related]
56. Does ICD indication affect quality of life and levels of distress?
Pedersen SS; Sears SF; Burg MM; Van Den Broek KC
Pacing Clin Electrophysiol; 2009 Feb; 32(2):153-6. PubMed ID: 19170902
[TBL] [Abstract][Full Text] [Related]
57. Renal insufficiency predicts the time to first appropriate defibrillator shock.
Hreybe H; Ezzeddine R; Bedi M; Barrington W; Bazaz R; Ganz LI; Jain S; Ngwu O; London B; Saba S
Am Heart J; 2006 Apr; 151(4):852-6. PubMed ID: 16569548
[TBL] [Abstract][Full Text] [Related]
58. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.
Hoogwegt MT; Kupper N; Jordaens L; Pedersen SS; Theuns DA
Europace; 2013 Oct; 15(10):1468-74. PubMed ID: 23608028
[TBL] [Abstract][Full Text] [Related]
59. Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease.
Habibović M; Versteeg H; Pelle AJ; Theuns DA; Jordaens L; Pedersen SS
Europace; 2013 Mar; 15(3):355-61. PubMed ID: 22989939
[TBL] [Abstract][Full Text] [Related]
60. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
Ingles J; Sarina T; Kasparian N; Semsarian C
Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
